# MANSMED (NCT03137186)

> Repurposing Metformin as Anticancer Drug: in Advanced Prostate Cancer

No report yet. It can be ordered.

- Drugs tested: metformin
- Indication: advanced prostate cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03137186
- Phase: PHASE2
- Status: UNKNOWN
- Sponsor: Mansoura University
- Conditions: Prostate Cancer
- Interventions: Metformin
- Enrollment: 120
- Primary outcome: duration in months from beginning of treatment till development of CRPC

## Indexed commentary on MANSMED so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 4 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=mansmed-nct03137186